Article metrics

Download PDFPDF

Original research
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: March 2020 to July 2020

AbstractFullPdf
Mar 2020384384147
Apr 202020820875
May 2020949441
Jun 202011611649
Jul 2020495118
Total851853330